MAC-545496

AdipoGen Life Sciences
Product Code: AG-CR1-0163
CodeSizePrice
AG-CR1-0163-M0011 mg£70.00
Quantity:
AG-CR1-0163-M0055 mg£190.00
Quantity:
AG-CR1-0163-M02525 mg£520.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
Ambient
Storage:
-20°C

Images

1 / 1
Chemical Structure

Chemical Structure

Further Information

Alternate Names/Synonyms:
N-((5-Chloropyridin-2-yl)carbamothioyl)-3-nitro-4-(piperidin-1-yl)benzamide
Appearance:
Yellow solid.
CAS:
838810-96-1
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Keep cool and dry.
InChi:
InChI=1S/C18H18ClN5O3S/c19-13-5-7-16(20-11-13)21-18(28)22-17(25)12-4-6-14(15(10-12)24(26)27)23-8-2-1-3-9-23/h4-7,10-11H,1-3,8-9H2,(H2,20,21,22,25,28)
InChiKey:
AFOKREIUUQFDNW-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 838810-96-1. Formula: C18H18ClN5O3S. MW: 419.9. MAC-545496 is a potent antimicrobial agent against MRSA. It works as a synthetic antibiotic adjuvant, a antivirulence and antibiofilm agent. Potent nanomolar inhibitor of glycopeptide-resistance-associated protein R (GraR), a regulator of the cell-envelope stress response that is an important virulence factor and determinant of antibiotic resistance. Antivirulence compound that reverses beta-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA) strains. MAC-545496 cripples MRSA?s ability to cause infection by diminishing its tolerance to the hostile components of the immune system and blocking the bacterium?s capacity to resist the action of several front-line antibiotics. Inhibits biofilm formation and abrogates intracellular survival in macrophages. MAC-545496 targets the bacteria in several different ways, it makes MRSA more susceptible to attack from the immune system, renders it vulnerable to the action of several antibiotics again and reduces the bacteria?s ability to produce biofilms.
MDL:
MFCD05848166
Molecular Formula:
C18H18ClN5O3S
Molecular Weight:
419.9
Package Type:
Vial
Product Description:
MAC-545496 is a potent antimicrobial agent against MRSA. It works as a synthetic antibiotic adjuvant, a antivirulence and antibiofilm agent. Potent nanomolar inhibitor of glycopeptide-resistance-associated protein R (GraR), a regulator of the cell-envelope stress response that is an important virulence factor and determinant of antibiotic resistance. Antivirulence compound that reverses beta-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA) strains. MAC-545496 cripples MRSA?s ability to cause infection by diminishing its tolerance to the hostile components of the immune system and blocking the bacterium?s capacity to resist the action of several front-line antibiotics. Inhibits biofilm formation and abrogates intracellular survival in macrophages. MAC-545496 targets the bacteria in several different ways, it makes MRSA more susceptible to attack from the immune system, renders it vulnerable to the action of several antibiotics again and reduces the bacteria?s ability to produce biofilms.
Purity:
>98% (HPLC)
SMILES:
ClC1=CC=C(NC(NC(C2=CC([N+]([O-])=O)=C(N3CCCCC3)C=C2)=O)=S)N=C1
Solubility Chemicals:
Soluble in DMSO, ethanol, methanol or dichloromethane.
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

References

Discovery of an antivirulence compound that reverses beta-lactam resistance in MRSA: O.M. El-Halfawy, et al.; Nat. Chem. Biol. 16, 143 (2020)